Here's what you can expect at Houston's Comicpalooza this weekend from esports to Game of Thrones stars

Bend the knee

Comicpalooza takes place Friday, May 9, to Sunday, May 12. Courtesy of Comicpalooza

People from around the world will be flocking to downtown Houston by the thousands, and not just for the Astros and the Rockets. The 11th annual Comicpalooza is taking over the George R. Brown Convention Center from Friday, May 10, to Sunday, May 12.

"This major super block in downtown will be absolutely electric this weekend," Michael Heckman, Comicpalooza president, tells InnovationMap.

Last year, the convention attracted over 50,000 people from 47 states and 17 countries, and it made an economic impact of over $20 million, Heckman says. This year, with the help of Game of Thrones stars and an inaugural ESPN event, Comicpalooza should surpass last year's accomplishments.

Here's what you can expect from this weekend.

A crowd at the panel that has two Game of Thrones actresses

Emilia Clarke (left) plays Daenerys in Game of Thrones, and Nathalie Emmanuel plays her adviser and friend, Missandei. Photos courtesy of Comicpalooza

A panel on Saturday morning at 11 am will have two Game of Thrones stars — Emilia Clarke (Daenerys) and Nathalie Emmanuel (Missandei). The panel is sure to attract the masses, and the two actresses are major gets by the organization.

"To be able to get Emilia Clarke in the middle of the final season of Game of Thrones, with only two episodes to go — the hype has been unbelievable," Heckman says. "To be able to have a pop culture phenomenon like that come here to Houston — and it will be her first fan event. She's done the San Diego Comic Con, but that was more of a media event."

Both actresses also have autograph visits available for purchase. Clarke's are sold out online, but some opportunities will be made available day of.

The first ever ESPN collegiate esports competition

ESPN's inaugural esports competition for college students is premiering at Comicpalooza. Jamie McInall/Pexels

For the first time ever, ESPN is having a collegiate esports championship and chose Houston to be the place for the finals.

"We've understood the value of [esports] for Comicpalooza for a number of years. ESPN is making a big investment — it's their first ever event of this nature, but it won't be their last," Heckman says.

Students from hundreds of schools have competed to make it to the semifinals and championship in Houston, and scholarships are on the line. The weekend will have 22 teams across five video games — Hearthstone, Heroes of the Storm, Overwatch, StarCraft II, and Street Fighter V — according to ESPN. To read more about the competition, click here.

Makers on display

Anyone can check out the Comicpalooza Maker's Space — there's even a place to fix any cosplay wardrobe malfunctions. Photo via comicpalooza.com

Calling all makers — professionals or wannabes. Comicpalooza's Maker's Space is open to cosplayers, artists, engineers, scientists and everyone in between who wants to create and build using old and new technology, from small electrical parts to towering 3D printers and Lego masterpieces.

"What a lot of people don't know is there are so many interesting aspects to Comicpalooza — from literature tracks to a film festival to a makerspace," Heckman says. "There are hundreds of exhibitors on the expo showfloor, but there's an area carved out for makers."

A party on the promenade

Free concert anyone? Photo via comicpalooza.com

From 6 to 10 pm on Saturday, Avenida Houston will be transformed into an after party put on by Saint Arnold's and headlined by Icona Pop. It's free to attend, and you can get more info here.

VIPs all around

It's not just the Game of Thrones people being featured. Photos via comicpalooza.com

Comicpalooza attendees can grab photos with or autographs from over 30 different actors across major franchises — like Star Trek, Walking Dead, and so much more.

The list of actors is as follows: Emilia Clarke, Nathalie Emmanuel, Grant Gustin, Wilmer Valderrama, Dan Fogler, Gates McFadden, Michael Dorn, John Wesley Shipp, Peter Serafinowicz, Griffin Newman, Yara Martinez, Brendan Hines, Scott Speiser, Jeremy Davies, Andrew Divoff, Mira Furlan, Erick Avari and more.

Michael Heckman shares about some exciting new aspects of Houston's 11th annual Comicpalooza. Courtesy of Houston First

Comicpalooza expects another record year, says Houston First Corp. executive

Featured Innovator

Eleven years ago, Comicpalooza was a small event held out in Katy. Over the past few years, with the help of Houston First Corp., the three-day conference has grown to be so big, the 2019 programming will spill out of George R. Brown Convention Center and into Discovery Green, and attract over 50,000 attendees.

"These comic conventions used to just be for the hardcore pop culture fans. What we've attempted to do is make it so there's something for everyone," says Michael Heckman, Comicpalooza president and senior vice president at Houston First. "As a casual pop culture fan, there's a lot to see and do."

The festivities take place Friday, May 10, to Sunday, May 12, and include some big name events. Two Game of Thrones stars — Emilia Clarke (Daenerys Targaryen) and Nathalie Emmanuel (Missandei) — will be on a panel, and ESPN will host its first collegiate esports competition.

Heckman tells InnovationMap more about these big events and how Comicpalooza has transformed over the years.

InnovationMap: How the event has grown over the past decade? 

Michael Heckman: We've really worked hard to increase the impact of the event. There's a lot of out of town visitors that do come in — it has north of a $20 million economic impact every year. When you look at an event that is held during a traditionally slow period of time, it's a really big deal for the hotels and restaurants. The other part about it is when you're able to bring big stars to Houston, they're tweeting about it and posting Instagram stories about it. It does a lot to shine a spotlight on Houston's reputation and image.

IM: What are you most excited about for this year?

MH: It's a big sprawling event that takes place across all 1.2 million square feet of GRBCC. I'm excited about a few things. First, we've got the two folks from Game of Thrones. To be able to get Emilia Clarke in the middle of the final season of Game of Thrones, with only two episodes to go — the hype has been unbelievable. To be able to have a pop culture phenomenon like that come here to Houston — and it will be her first fan event. She's done the San Diego Comic Con, but that was more of a media event.

We've also got the ESPN Collegiate Esports Championship held here. We've done esports and gaming over the past few years, but it's a growth area for the event. To be able to hold that event with dozens of championships from around the country for this inaugural event is very exciting.

What a lot of people don't know is there are so many interesting aspects to Comicpalooza — from literature tracks to a film festival to a makerspace. There are hundreds of exhibitors on the expo showfloor, but there's an area carved out for makers. We have NASA, a cultural arts avenue, there's something for everyone. We're really looking forward to a blockbuster year.

IM: What did it mean for Houston to get ESPN’s collegiate esports program? 

MH: Esports is rapidly growing. That marketplace is developing very quickly. A lot of people and a lot of cities are figuring out what that means. We've understood the value of it for Comicpalooza for a number of years. ESPN is making a big investment — it's their first ever event of this nature, but it won't be their last.

IM: How did it come about?

MH: We've been talking to a number of folks across the landscape about how to best utilize the space that we have at GRBCC and find an opportunity that was a good fit for us. A couple people we were talking to out on the West Coast who connected us to the ESPN people, who happen to be the same division of ESPN that partners with the Houston Texans on a couple things. There's some synergies there, and they're familiar with Houston.

IM: How would you describe Comicpalooza's economic impact on Houston?

MH: Around 20 to 30 percent for the audience of Comicpalooza comes from outside of Houston. Last year, we had attendees from 47 states and 17 countries. It gives great exposure to the city, and the money they leave behind is valuable from an economic impact perspective. We think our numbers will be somewhat similar to last year.

If you look at the long term vision of what this could be, we have a beautiful campus for this event. We've moved some of our programming outside GRBCC onto the Avenida Plaza that connects to Discovery Green. If we have a full campus-wide event, that's something that's highly attractive. You grow that attendance, get up to 70 or 80 thousand people — that's a mega event. It's a snowball — once you get it started and then it just takes off. We're not there yet, but we've had really smart growth.

IM: How is the city as a whole preparing for the event?

MH: Houston's really good about handling events. It takes everything from the fire department to the police department and traffic control and 700 event volunteers — over 2,000 shifts. It's such a big footprint — it's kind of all hands on deck. It also looks like we'll have Astros at home and the Rockets playing game six of the playoffs at home. This major super block in downtown will be absolutely electric this weekend.

IM: What other events are you looking to bring to Houston?

MH: We'll always be chasing our conventions we have here. Our convention sales team looks to break another record this year. We have a lot of major events upcoming — from the college football playoff to the men's basketball Final Four, and we'll eventually pursue another Super Bowl. As we look to develop our portfolio of events that we manage here, there's a lot of opportunities here for events centered around innovation. There's a lot of talk around how Houston needs to have a better reputation for innovation. We've got aerospace, medical, oil and gas — what's an event we can create or partner on that could highlight Houston's innovation.

------

Portions of this interview have been edited.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings